Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/13/2012 | US20120231017 Heterocyclic aspartyl protease inhibitors |
09/13/2012 | US20120231013 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
09/13/2012 | US20120231012 Diagnosis, treatment, and prevention of vascular disorders using interleukin-1 autoantibodies |
09/13/2012 | US20120231006 Anti-orai1 antigen binding proteins and uses thereof |
09/13/2012 | US20120231003 Ox2 Receptor Homologs |
09/13/2012 | US20120231002 Treatment of vasculoproliferative conditions |
09/13/2012 | US20120230998 Ip-10 antibodies and their uses |
09/13/2012 | US20120230996 Compositions And Methods For Macular Degeneration |
09/13/2012 | US20120230992 Vegf-related protein |
09/13/2012 | US20120230955 Arabinoxylans for modulating the barrier function of the intestinal surface |
09/13/2012 | US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability |
09/13/2012 | CA2830706A1 Quinolinone derivatives |
09/13/2012 | CA2829259A1 Use of vanadium compounds for maintaining normaglycemia in a mammal |
09/13/2012 | CA2829187A1 Dipyridylamine derivative |
09/13/2012 | CA2829128A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
09/13/2012 | CA2829037A1 Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces |
09/13/2012 | CA2829006A1 Locally released growth factors to mediate motor recovery after stroke |
09/12/2012 | EP2497498A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
09/12/2012 | EP2497489A1 Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
09/12/2012 | EP2497488A1 Method for treating delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA |
09/12/2012 | EP2497487A1 Method for treating diabetes and atherosclerosis associated with changes of qualitative and/quantitative composition of blood extracellular DNA |
09/12/2012 | EP2497486A1 Method for treating diseases caused by fungi associated with changes of qualitative and/quantitative composition of blood extracellular DNA |
09/12/2012 | EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
09/12/2012 | EP2496238A1 Lipid formulated compositions and methods for inhibiting expression of transthyretin (ttr) |
09/12/2012 | CN102666580A Glycosylated form of antigenic GLP-1 analogue |
09/12/2012 | CN102666563A Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2A R agonists |
09/12/2012 | CN102666542A Pyrazolopyrimidine derivatives |
09/12/2012 | CN102666535A Imidazole derivatives as aldosterone synthase inhibitors |
09/12/2012 | CN102666531A Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
09/12/2012 | CN102666507A Oxazine derivatives and their use in the treatment of neurological disorders |
09/12/2012 | CN102666500A Seven-membered ring compound and pharmaceutical use therefor |
09/12/2012 | CN102666476A Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease |
09/12/2012 | CN102665733A Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders |
09/12/2012 | CN102665725A Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
09/12/2012 | CN102665714A Treatment of atrial fibriallation |
09/12/2012 | CN102665713A Method of treating atrial fibrillation |
09/12/2012 | CN102665698A Combination composition useful for treating cardiovascular diseases |
09/12/2012 | CN102660617A Application of alga used for preparing angiotensin converting enzyme inhibitor |
09/12/2012 | CN102660548A Preparation and application of South China sea conus textile conotoxin TxO10 |
09/12/2012 | CN102660523A Low-immunogenicity lumbrukinase, preparation method and application thereof |
09/12/2012 | CN102660419A Multifunctional health-care wine |
09/12/2012 | CN102659945A Anti-C5aR antibodies and uses thereof |
09/12/2012 | CN102659944A IL-18 binding proteins |
09/12/2012 | CN102659871A Method for extracting and refining anthocyanin in black rice |
09/12/2012 | CN102659803A Sesterterpene compound and preparation method and application thereof |
09/12/2012 | CN102659793A Phthalocyanine silicon modified by amino ethyl groups and phenoxy groups as well as preparation method and application thereof |
09/12/2012 | CN102659783A N-substituted sophora flavescens olefine acid derivative as well as preparation method and application thereof |
09/12/2012 | CN102659569A Royal jelly acid calcium, and health product for antiatherosclerosis and antiosteoporosis prepared from royal jelly acid calcium and vitamin K2 |
09/12/2012 | CN102657875A ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof |
09/12/2012 | CN102657840A Stasis-removing and inflammation-diminishing traditional Chinese medicine composition, stasis-removing and inflammation-diminishing pills, stasis-removing and inflammation-diminishing plaster and preparation method thereof |
09/12/2012 | CN102657839A Traditional Chinese medicine capsule for treating coronary heart disease |
09/12/2012 | CN102657835A Composition and medical liquor for treatment of high blood pressure/rheumatoid arthritis and preparation method and application of composition and medical liquor |
09/12/2012 | CN102657828A Pharmaceutical composition for treating chronic heart failure |
09/12/2012 | CN102657820A Traditional Chinese medicine for treating cerebral infarction |
09/12/2012 | CN102657818A Drug for treating infusion phlebitis and preparation method thereof |
09/12/2012 | CN102657806A Combination tablets for dissipating bruise, promoting the circulation of qi, activating yang and removing stasis |
09/12/2012 | CN102657802A Traditional Chinese medicine for treating diabetic feet |
09/12/2012 | CN102657774A Traditional Chinese medicine for treating diabetic hypertension |
09/12/2012 | CN102657747A Method for extracting and purifying saffron by-product petal and stamen total flavone |
09/12/2012 | CN102657718A Preparation method for high content fructus crataegi flavone |
09/12/2012 | CN102657711A Cerebral apoplexy treatment medicament and preparation method thereof |
09/12/2012 | CN102657704A Herbal tea for treating haemorrhoids and preparation method thereof |
09/12/2012 | CN102657697A Propranolol-eugenol type basil oil nano-emulsion medicament and preparation method thereof |
09/12/2012 | CN102657694A Quick production process for liquorice extract by high-voltage pulsed electric field |
09/12/2012 | CN102657691A Extraction process of carthamin yellow |
09/12/2012 | CN102657688A Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof |
09/12/2012 | CN102657671A Troxerutin and ligustrazine combined preparation and application thereof |
09/12/2012 | CN102657660A Application of total triterpenes in preparing drugs inhibiting angiogenesis |
09/12/2012 | CN102657658A Medicine composition for treating myocardial infarction, vascular circulatory disturbance and thrombosis |
09/12/2012 | CN102657657A Capsule containing valsartan, amlodipine and hydrochlorothiazide |
09/12/2012 | CN102657656A Composition and methods for modulating a kinase cascade |
09/12/2012 | CN102657651A Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
09/12/2012 | CN102657648A Drug for treating hypertension and preparation method thereof |
09/12/2012 | CN102657647A Application of IC-4 in antiangiogenesis |
09/12/2012 | CN102657646A Medicinal composition and preparation thereof |
09/12/2012 | CN102657638A Sodium ferulate lyophilized powder composition for injection and preparation method thereof |
09/12/2012 | CN102657621A Diltiazem hydrochloride freeze-dry powder injection for injection |
09/12/2012 | CN102657615A Vincamine sustained-release pellet preparation and preparation method thereof |
09/12/2012 | CN102657608A Trimetazidine dihydrochloride composition and preparation method thereof |
09/12/2012 | CN102657604A Oral liquid for treating vertigo and vomitting |
09/12/2012 | CN102225088B Application of Eucommia lignans in preparing medicaments for preventing and treating hypertension-induced renal injury |
09/12/2012 | CN102180832B Compound for protecting cerebral ischemia and preparation method thereof |
09/12/2012 | CN102178650B Alprostadil injection and preparation method thereof |
09/12/2012 | CN102048939B Medicament for treating sinus bradycardia |
09/12/2012 | CN102018959B Method and reagent for preventing and treating heart disease |
09/12/2012 | CN101928280B Pepperphentonamine derivative containing naphthalene rings |
09/12/2012 | CN101805688B Mulberry health-care wine and preparation method thereof |
09/12/2012 | CN101781347B Polymorphic substances of decitabine and medical compositions |
09/12/2012 | CN101760446B Method for preparing monocyte type stem cell and application |
09/12/2012 | CN101744806B Application of pinocembrin raceme in preparation of medicals for cerebral apoplexy |
09/12/2012 | CN101732276B Tablet of isosorbide mononitrate |
09/12/2012 | CN101627992B Application of levo butyl phthalide in preparing brain stroke medicament |
09/12/2012 | CN101612151B Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation |
09/12/2012 | CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase |
09/12/2012 | CN101401842B Chinese medicinal composition |
09/12/2012 | CN101342208B Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia and preparation method thereof |
09/12/2012 | CN101257900B Gsk-3 inhibitors |
09/11/2012 | US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide |
09/11/2012 | US8263634 Heteroaryl-ureas and their use as glucokinase activators |
09/11/2012 | US8263615 Bis-heterocyclic imidazolyl compounds |